Physician profile
Laurie Deluca
NPI 1740235738
$1,139.98
in general payments reported to CMS, 2019-2025
12 companies · $68.13 in 2025
The $68.13 reported for 2025 was less than what a typical Undersea and Hyperbaric Medicine (Emergency Medicine) provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $337 · 2021: $28.00 · 2022: $13.77 · 2023: $611 · 2024: $81.58 · 2025: $68.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $761.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $337.17 | 2019 | |
| Abbvie INC. | $217.71 | 2023-2024 | Dalvance, Teflaro, Botox |
| Next Science LLC | $142.17 | 2023 | Blastx, Xperience, Surgx |
| Nevro Corp. | $122.99 | 2023 | Senza |
| Tactile Systems Technology INC | $68.13 | 2025 | Nimbl, Flexitouch Plus |
| Organogenesis INC. | $49.83 | 2023 | Puraply |
| Kci USA, INC. | $44.52 | 2023 | Activ.A.C., V.A.C. Dermatac, Kerramax Care |
| Allergan, INC. | $41.77 | 2021-2022 | |
| Smith+Nephew, INC. | $40.31 | 2023 | Collagenase Santyl |
| Hydrofera LLC | $35.83 | 2023 | Hydrofera Blue |
| Melinta Therapeutics, LLC | $20.38 | 2023 | Orbactiv, Kimyrsa |
| Convatec INC. | $19.17 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurie Deluca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.